A recent study identifies an immune cell type known as classical monocytes in the peripheral blood as a potential biomarker for response to anti-PD-1 immune checkpoint therapy in metastatic melanoma.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Epigenetic reprogramming of Runx3 reinforces CD8 + T-cell function and improves the clinical response to immunotherapy
Molecular Cancer Open Access 16 May 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sharma, P. & Allison, J.P. Cell 161, 205–214 (2015).
Sharma, P., Hu-Lieskovan, S., Wargo, J.A. & Ribas, A. Cell 168, 707–723 (2017).
Larkin, J. et al. N. Engl. J. Med. 373, 23–34 (2015).
Wolchok, J.D. et al. N. Engl. J. Med. 377, 1345–1356 (2017).
Michot, J.M. et al. Eur. J. Cancer 54, 139–148 (2016).
Krieg, C. et al. Nat. Med. 24, 144–153 (2018).
Sharma, P. Cancer J. 22, 68–72 (2016).
Le, D.T. et al. Science 357, 409–413 (2017).
Gao, J. et al. Nat. Med. 23, 551–555 (2017).
Zarour, H.M. Clin. Cancer Res. 22, 1856–1864 (2016).
Hanna, R.N. et al. Science 350, 985–990 (2015).
Romano, E. et al. Proc. Natl. Acad. Sci. USA 112, 6140–6145 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Goswami, S., Basu, S. & Sharma, P. A potential biomarker for anti-PD-1 immunotherapy. Nat Med 24, 123–124 (2018). https://doi.org/10.1038/nm.4489
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4489
This article is cited by
-
Epigenetic reprogramming of Runx3 reinforces CD8 + T-cell function and improves the clinical response to immunotherapy
Molecular Cancer (2023)
-
Recent advances in sonodynamic immunotherapy
Journal of Cancer Research and Clinical Oncology (2023)
-
Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer
The Pharmacogenomics Journal (2020)